Sept. 4–5, 2019 • Houston, Texas
Building upon the success of 2018’s Interim Workshop on Cancer Immune Responsiveness (CIR), the goal of this year’s CIR workshop is the continued advancement of knowledge in the field about interactions between the immune system and cancer that contribute to immunotherapy response and resistance.
Over this two-day workshop, participants will take part in both didactic sessions and working groups to identify and address key questions in the field concerning cancer immune responsiveness.
Topics to be discussed include:
Attendee participation will greatly assist in defining and expanding upon pivotal questions concerning mechanisms of cancer immune responsiveness/resistance in order to advance improved therapeutic strategies and patient benefit with immunotherapy. It is anticipated that the efforts of numerous attendee-driven working groups will further momentum in the field by continuing discussions aimed at addressing the critical questions generated within this workshop well into the future.
This second-year workshop will further the suggestions and recommendations derived from the 2018 workshop, help to educate the scientific community on the status and direction of immunotherapy research related to immune responsiveness, and will culminate in a manuscript to be submitted for publication in the Journal for ImmunoTherapy of Cancer (JITC).
Alessandra Cesano, MD, PhD – NanoString Technologies, Inc. Francesco M. Marincola, MD – Refuge Biotechnologies, Inc.
Upon completion of this meeting, participants will be able to:
Royal Sonesta Houston2222 West South LoopHouston, TexasClick below to make your hotel reservation by Wednesday, August 14 to receive a discounted rate. Reserve Your Hotel Room
or to speak to a Reservations Representative, call 1-855-463-3091.
Participants receive a 30 percent discount when registering for both the Cancer Immune Responsiveness and Adoptive Cellular Therapies workshops.
Both workshops will help attendees stay at the forefront of new technologies that will impact clinical practice and highlight emerging topics relevant to the immuno-oncology field.
Four collaborative sessions, taking place the morning of Sept. 5, will allow attendees from both workshops to discuss commonalities regarding external circumstantial factors, the state of the field, and new concepts that impact cancer immune responsiveness and adoptive cellular therapies.
CIR WORKSHOP SCHEDULE
ACT WORKSHOP SCHEDULE
Tel: +1 414 271 2456 | Fax: +1 414 276 3349 | Email: email@example.com